Champions Oncology (CSBR) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for October 14, 2024, at company headquarters in Hackensack, NJ.

• Record date for voting eligibility is August 26, 2024, with 13,593,766 shares outstanding.

• Proxy materials are available online, and shareholders are encouraged to vote electronically or by mail.

Voting matters and shareholder proposals

• Election of seven director nominees for a one-year term.

• Ratification of EisnerAmper LLP as independent auditor for fiscal year ending April 30, 2025.

• Advisory vote on executive compensation (say-on-pay).

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of seven members, six of whom are independent under Nasdaq rules.

• Board met three times in fiscal 2024; all directors attended at least 75% of meetings.

• Committees: Audit, Compensation, and Nominating & Corporate Governance, all with independent members.

• Board diversity matrix provided; no formal diversity policy, but candidates are selected based on merit.

• Separate CEO and Chairman roles; risk oversight is a board responsibility.